Possible Consequences for the Pharma Industry if the USP Revision of the General Chapters 41 and 1251 is Enacted
Add bookmarkPossible Consequences for the Pharma Industry if the USP Revision of the General Chapters 41 and 1251 is Enacted
Add bookmark
Expected for a long time, USP has published a new draft to revise the General Chapters 41 “Balances” and 1251 “Weighing on an Analytical Balance” in the Pharmacopeial Forum PF 38(5) on September 4, 2012. One consequence of General Chapter 41 is the so-called minimum weight, which needs to be adhered to in order to fulfill applicable accuracy requirements for weighing systems.
It is very important to understand that the concept of minimum weight is not only restricted...
Tags:
Klaus Fritsch
USP General Chapter 1251
accuracy
routine testing
FDA
ISPE
USP General Chapter 41
